Shukla Sath 4
4 · Spero Therapeutics, Inc. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
Shukla Sath
CEO & President
Transactions
- Award
Stock Option (right to buy)
2021-01-04+75,000→ 75,000 totalExercise: $17.93Exp: 2031-01-04→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% on January 4, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.